ABCSG 8 - Adjuvant Treatment in Patients With Hormone Receptor-positive Breast Cancer With Good to Moderate Differentiation.
Clinical trial NCT00291759 · COMPLETED
Trial details
- NCT number
- NCT00291759
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1996-01-01
- Primary completion
- 2009-06-01
- Enrollment
- 3858
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.